Skip to main content
. 2015 Sep 4;6(31):30939–30956. doi: 10.18632/oncotarget.5132

Figure 6. Effects of B5 on ASK1 and p38/JNK MAPKs.

Figure 6

A. CaSki and SiHa cells were treated with 16 μM B5 for 8h; ASK1-Trx complex was precipitated using Protein A beads and analyzed by western blotting with ASK1 and Trx antibodies. B. Activation of p38/JNK MAPKs. Cells were treated with 16 μM B5 for 0, 6, 12 and 24 h and subjected to western blotting analysis; GAPDH was used as the internal control.

HHS Vulnerability Disclosure